» Articles » PMID: 30508964

Hemangiomas of the Tongue and the Oral Cavity in a Myotonic Dystrophy Type 1 Patient: A Case Report

Overview
Specialty General Medicine
Date 2018 Dec 5
PMID 30508964
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Myotonic dystrophy type 1 (DM1) is an autosomal dominant disease caused by a cytosine, guanine, thymine (CTG) trinucleotide repeat expansion in the non-coding region of dystrophia myotonica protein kinase gene, causing a multisystem involvement. To date, few studies have been performed to evaluate skin features in DM1 patients, but none reported on the possible association between the disease and tongue hemangiomas.

Patients Concerns: We report a case of a 63-year-old woman affected by DM1 and presenting, at the intraoral examination, several swelling and buish lesions occurring on buccal and palatal mucosa, and in the anterior two-thirds and margins of the tongue.

Diagnosis: Multiple tongue hemangiomas in DM1 patient.

Interventions: Color Doppler ultrasound revealed hypoechoic lesions with intermittent color picking suggestive of vascular lesion. Surgical excision was performed under general anesthesia. Histopathological examination was compatible with the diagnosis of cavernous hemangiomas.

Outcomes: At 6 months follow-up, a part from the cosmetic deformity, patient's hemangiomas did not bleed, but caused functional problems with speaking, mastication, and deglutition, in addition to the same symptoms induced by DM1.

Lessons: This case may add new details to better characterize the DM1 phenotype, suggesting that even tongue hemangiomas may be part of the DM1 multisystem involvement.

Citing Articles

Anesthetic Management of a Patient With a Giant Hemangioma Who Required Urgent Embolization for Bleeding During Third Molar Extractions.

Yamamoto T, Kurata S, Ujita T, Kishimoto N, Imai Y, Sawada E Anesth Prog. 2024; 71(4):183-187.

PMID: 39711453 PMC: 11614468. DOI: 10.2344/23-0038.


Transoral surgery with Thunderbeat© for hemangioma of the tongue base: A novel procedure. Case report.

Saraniti C, Burrascano D, Comincini I, Martorana A, Verro B Int J Surg Case Rep. 2024; 116:109385.

PMID: 38350379 PMC: 10943972. DOI: 10.1016/j.ijscr.2024.109385.


Comorbidities in Androgenetic Alopecia: A Comprehensive Review.

Chen S, Xie X, Zhang G, Zhang Y Dermatol Ther (Heidelb). 2022; 12(10):2233-2247.

PMID: 36115913 PMC: 9483356. DOI: 10.1007/s13555-022-00799-7.


Cutaneous findings in myotonic dystrophy.

Kong H, Pollack B JAAD Int. 2022; 7:7-12.

PMID: 35243403 PMC: 8867117. DOI: 10.1016/j.jdin.2021.09.008.

References
1.
Mueller C, Hilbert J, Martens W, Thornton C, Moxley 3rd R, Greene M . Hypothesis: neoplasms in myotonic dystrophy. Cancer Causes Control. 2009; 20(10):2009-20. PMC: 3110730. DOI: 10.1007/s10552-009-9395-y. View

2.
Ueda H, Ohno S, Kobayashi T . Myotonic dystrophy and myotonic dystrophy protein kinase. Prog Histochem Cytochem. 2000; 35(3):187-251. DOI: 10.1016/s0079-6336(00)80002-9. View

3.
Kamei J, Toyofuku T, Hori M . Negative regulation of p21 by beta-catenin/TCF signaling: a novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochem Biophys Res Commun. 2003; 312(2):380-7. DOI: 10.1016/j.bbrc.2003.10.129. View

4.
Bianchi M, Leoncini E, Masciullo M, Modoni A, Gadalla S, Massa R . Erratum to: Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors. J Neurol. 2016; 263(3):499. DOI: 10.1007/s00415-016-8068-5. View

5.
Gadalla S, Hilbert J, Martens W, Givens S, Moxley 3rd R, Greene M . Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy. Eur J Neurol. 2017; 24(5):713-718. PMC: 5464410. DOI: 10.1111/ene.13276. View